Weekly Market Recap. April 30- May 4, 2018


04-May-2018 16:37 PM



   If you missed this week all the market news and mover. Here is the recap:

Monday U.S. Market pullback ahead of  Fed rate decision and waiting for Apple Inc (AAPL) earnings report on Tuesday. Economic data Pending Homes Sales 0.4% vs 0.6%, and Personal Spending 0.4% vs 0.4%. Dow Jones -148.04 points, SPY -0.77%, QQQ -0.47%, IWM -0.89% and IBB -1.86%.

  Tuesday Dow falls 150 points intraday as Wall Street awaits Apple earnings. Dow closed -64.10 points, SPY +0.18%, QQQ +1.14%, IWM +0.49% and IBB +0.40%.

  Wednesday Fed FOMC minutes keep the rate unchanged, 'risk of economic outlook appear roughly balanced. Dow Jones -174.07 points, IWM +0.38%, QQQ -0.59%, IBB -1.32%

  Thursday economy data: ISM Non-Manufacturing PMI 56.8 vs 58.10, Initial Jobless Claims 211k vs 225k est. Today was a wild day, Down Jones dropped -400 points intraday before recovery back to green close +5.17 points, IBB -1.36%, IWM -0.54%, QQQ -0.01%.

  Friday U.S. Payrolls rise 164k and Jobless Rate Falls to 3.9%. Dow Jones closed up +332.36 points, SPY+1.29%, IBB +1.06%, QQQ +1.90%, IWM +1.25%. 


  • Steadymed Ltd (STDY) buyout from United Therapeutics for $4.46 per share in cash
  • T-Mobile US, Inc (TMUS) agrees to buy Sprint Corp (S) for $26 billion deal.
  • McDonald's Corp (MCD) earnings report


  • Shopify Inc (SHOP) earnings report Q1 EPS 4c vs (5c). Revenue $214.3M vs $202.23M. Stock close down -4.45%
  • Karyopharm Therapeutics (KPTI) positive Phase 2b data. Stock closeup +10.93%
  • Nutrisystem Inc (NTRI) earning report beat. Q1 EPS $9c vs 6c, revenue $210.9M vs $207.3M. Stock closeup +18.10%




  • Portola Pharmaceuticals Inc (PTLA)- Andexxa approved by FDA
  • Arista Networks (ANET) earnings report Q1 EPS $1.79 vs $1.51
  • Apple Inc (AAPL)- Warren Buffett's Berkshire Hathaway bought 75 million shares of Apple, in the first quarter.

Thanks for reading.

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.